Search

everythinglearnresearchcommunity

for

Search:↓

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Rats had lasting erectile problems after stopping a certain medication.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Tamsulosin and finasteride have similar effects on blood sugar control in men with type 2 diabetes.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Urologists should screen for mental health issues before and during finasteride treatment.